Limits...
Calcium-Sensing Receptor in Human Peripheral Blood T Lymphocytes Is Involved in the AMI Onset and Progression through the NF- κ B Signaling Pathway

View Article: PubMed Central - PubMed

ABSTRACT

Acute myocardial infarction (AMI) is a condition triggered by an inflammatory process that seriously affects human health. Calcium-sensing receptor (CaSR) in T lymphocytes is involved during the inflammation reaction. However, the relationship between them is not very clear. In this study, we collected human peripheral blood T lymphocytes from patients with AMI and in different stages of percutaneous coronary intervention (PCI) (at the onset of AMI, the first day after PCI (PCI-1), PCI-3, and PCI-5) to study the CaSR and NF-κB pathway protein expression, cytokine release and T cell apoptosis. The results showed that the expressions of CaSR, P-p65, Caspase-12, and the secretions of Th-1 and Th-2 type cytokines were increased at the onset of AMI, especially on the PCI-1. Meanwhile, the apoptosis rate of CD3+, CD4+ and CD8+ T lymphocytes also increased. However, from PCI-3, all the indicators began to decline. In addition, we also found that positive CaSR small interfering RNA (siRNA) transfection in T lymphocytes and NF-κB pathway blocker Bay-11-7082 reversed the increased expressions of CaSR, P-p65, Caspase-12, reduced the secretions of Th-1 and Th-2 type cytokines, and decreased T lymphocytes apoptosis rate not only in the AMI patients but also in the normal controls. All of these results indicated that CaSR in the human peripheral blood T lymphocytes were involved in the AMI onset and progression, which probably was related to the NF-κB pathway. Our study demonstrated the relationship between AMI and CaSR, and will provide new effective prevention theory and new targets for drug treatment.

No MeSH data available.


Related in: MedlinePlus

Silence effect of CaSR small interfering RNA (siRNA) transfection. T lymphocytes were transfected with 5 μg positive plasmid or negative plasmid. Protein or mRNA was harvested 24 h post-transfection. Western blot (A) and qRT-PCR (B) results showed that the positive CaSR siRNA plasmid transfection in T lymphocytes reduced the expressions of CaSR mRNA and protein, which increased remarkably in AMI patients. In addition, negative plasmid of CaSR siRNA had no effect on the CaSR expression. * p < 0.05 vs. normal group; Δp < 0.05 vs. AMI group.
© Copyright Policy
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC5037677&req=5

ijms-17-01397-f003: Silence effect of CaSR small interfering RNA (siRNA) transfection. T lymphocytes were transfected with 5 μg positive plasmid or negative plasmid. Protein or mRNA was harvested 24 h post-transfection. Western blot (A) and qRT-PCR (B) results showed that the positive CaSR siRNA plasmid transfection in T lymphocytes reduced the expressions of CaSR mRNA and protein, which increased remarkably in AMI patients. In addition, negative plasmid of CaSR siRNA had no effect on the CaSR expression. * p < 0.05 vs. normal group; Δp < 0.05 vs. AMI group.

Mentions: In order to better clarify the role of CaSR in T cells in AMI and PCI, we want to silence the CaSR to observe the effect. Both of the qRT-PCR and Western blot results showed that the expressions of CaSR mRNA and protein in T lymphocytes increased remarkably in AMI patients compared with the normal controls. However, the positive CaSR siRNA plasmid transfection in T lymphocytes reduced the expressions of both CaSR mRNA and protein (p < 0.05). In addition, negative plasmid of CaSR siRNA had no effect on the CaSR expression both in the normal and AMI groups (Figure 3).


Calcium-Sensing Receptor in Human Peripheral Blood T Lymphocytes Is Involved in the AMI Onset and Progression through the NF- κ B Signaling Pathway
Silence effect of CaSR small interfering RNA (siRNA) transfection. T lymphocytes were transfected with 5 μg positive plasmid or negative plasmid. Protein or mRNA was harvested 24 h post-transfection. Western blot (A) and qRT-PCR (B) results showed that the positive CaSR siRNA plasmid transfection in T lymphocytes reduced the expressions of CaSR mRNA and protein, which increased remarkably in AMI patients. In addition, negative plasmid of CaSR siRNA had no effect on the CaSR expression. * p < 0.05 vs. normal group; Δp < 0.05 vs. AMI group.
© Copyright Policy
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC5037677&req=5

ijms-17-01397-f003: Silence effect of CaSR small interfering RNA (siRNA) transfection. T lymphocytes were transfected with 5 μg positive plasmid or negative plasmid. Protein or mRNA was harvested 24 h post-transfection. Western blot (A) and qRT-PCR (B) results showed that the positive CaSR siRNA plasmid transfection in T lymphocytes reduced the expressions of CaSR mRNA and protein, which increased remarkably in AMI patients. In addition, negative plasmid of CaSR siRNA had no effect on the CaSR expression. * p < 0.05 vs. normal group; Δp < 0.05 vs. AMI group.
Mentions: In order to better clarify the role of CaSR in T cells in AMI and PCI, we want to silence the CaSR to observe the effect. Both of the qRT-PCR and Western blot results showed that the expressions of CaSR mRNA and protein in T lymphocytes increased remarkably in AMI patients compared with the normal controls. However, the positive CaSR siRNA plasmid transfection in T lymphocytes reduced the expressions of both CaSR mRNA and protein (p < 0.05). In addition, negative plasmid of CaSR siRNA had no effect on the CaSR expression both in the normal and AMI groups (Figure 3).

View Article: PubMed Central - PubMed

ABSTRACT

Acute myocardial infarction (AMI) is a condition triggered by an inflammatory process that seriously affects human health. Calcium-sensing receptor (CaSR) in T lymphocytes is involved during the inflammation reaction. However, the relationship between them is not very clear. In this study, we collected human peripheral blood T lymphocytes from patients with AMI and in different stages of percutaneous coronary intervention (PCI) (at the onset of AMI, the first day after PCI (PCI-1), PCI-3, and PCI-5) to study the CaSR and NF-&kappa;B pathway protein expression, cytokine release and T cell apoptosis. The results showed that the expressions of CaSR, P-p65, Caspase-12, and the secretions of Th-1 and Th-2 type cytokines were increased at the onset of AMI, especially on the PCI-1. Meanwhile, the apoptosis rate of CD3+, CD4+ and CD8+ T lymphocytes also increased. However, from PCI-3, all the indicators began to decline. In addition, we also found that positive CaSR small interfering RNA (siRNA) transfection in T lymphocytes and NF-&kappa;B pathway blocker Bay-11-7082 reversed the increased expressions of CaSR, P-p65, Caspase-12, reduced the secretions of Th-1 and Th-2 type cytokines, and decreased T lymphocytes apoptosis rate not only in the AMI patients but also in the normal controls. All of these results indicated that CaSR in the human peripheral blood T lymphocytes were involved in the AMI onset and progression, which probably was related to the NF-&kappa;B pathway. Our study demonstrated the relationship between AMI and CaSR, and will provide new effective prevention theory and new targets for drug treatment.

No MeSH data available.


Related in: MedlinePlus